Sources | Names Used |
---|---|
CTRPv2 | cyanoquinoline 11 |
PharmacoGx | cyanoquinoline 11 |
Database | Identifier |
---|---|
Smiles: | Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cnc[nH]4)cc23)C#N)cc1Cl |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD160 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | ARL2BP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | ARHGAP28 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | MAN2B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | STK32A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | ITGB1BP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | SLC35F1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | GON4L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |